These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5002739)

  • 1. The source of the inter-alpha trypsin inhibitor in pathologic hyaluronateprotein.
    Becker A; Sandson J
    Arthritis Rheum; 1971; 14(6):764-6. PubMed ID: 5002739
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteinase inhibitors in human synovial fluid.
    Shtacher G; Maayan R; Feinstein G
    Biochim Biophys Acta; 1973 Mar; 303(1):138-47. PubMed ID: 4121912
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding of haptoglobin, inter-alpha-trypsin inhibitor, and alpha 1 proteinase inhibitor to synovial fluid hyaluronate and the influence of these proteins on its degradation by oxygen derived free radicals.
    Hutadilok N; Ghosh P; Brooks PM
    Ann Rheum Dis; 1988 May; 47(5):377-85. PubMed ID: 2455485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complex-formation with hyaluronic acid as a cause of fibronectin heterogeneity in the synovial fluid].
    Abdullin AR; Litvinov RI; Zinkevich OD; Zubairov DM; Salikhov IG
    Vopr Med Khim; 1987; 33(4):101-4. PubMed ID: 3660729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered properties of pathological hyaluronate due to a bound inter-alpha trypsin inhibitor.
    Sandson J; Hamerman D; Schwick G
    Trans Assoc Am Physicians; 1965; 78():304-13. PubMed ID: 4955886
    [No Abstract]   [Full Text] [Related]  

  • 6. Glycosaminoglycans in articular pathology.
    Caygill JC
    Ann Biol Clin (Paris); 1971; 29(1):85-90. PubMed ID: 4252901
    [No Abstract]   [Full Text] [Related]  

  • 7. BINDING OF AN ALPHA GLOBULIN TO HYALURONATEPROTEIN IN PATHOLOGICAL SYNOVIAL FLUIDS.
    SANDSON J; HAMERMAN D
    Science; 1964 Oct; 146(3640):70-1. PubMed ID: 14173029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid in human synovial effusions; a sensitive indicator of altered connective tissue cell function during inflammation.
    Castor CW; Prince RK; Hazelton MJ
    Arthritis Rheum; 1966 Dec; 9(6):783-94. PubMed ID: 5297217
    [No Abstract]   [Full Text] [Related]  

  • 9. Complement components in synovial fluid: activation and fixation in seropositive rheumatoid arthritis.
    Ruddy S; Britton MC; Schur PH; Austen KF
    Ann N Y Acad Sci; 1969 Dec; 168(1):161-72. PubMed ID: 4987687
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recent data on the complement in articular pathology].
    Peltier AP
    J Belge Rhumatol Med Phys; 1967; 22(4):276-87. PubMed ID: 5619165
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxyproline metabolism in serum, synovial fluid ans synovial membrane in joint diseases.
    Igari T; Tsuchizawa M; Obara K; Ono S
    Nihon Geka Hokan; 1968 Nov; 37(6):836-41. PubMed ID: 5751724
    [No Abstract]   [Full Text] [Related]  

  • 12. The association of hyaluronic acid with protein in human synovial fluid.
    How MJ; Long VJ; Stanworth DR
    Biochim Biophys Acta; 1969 Nov; 194(1):81-90. PubMed ID: 4982055
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plasma and synovial fibronectin. Results of personal research].
    Lecocq J; North ML; Grange D; Hauptmann G; Kuntz JL; Meyer R; Asch L
    Rev Rhum Mal Osteoartic; 1984; 51(7-8):393-8. PubMed ID: 6494778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viscoelasticity of "normal" and pathological synovial fluid.
    Anadere I; Chmiel H; Laschner W
    Biorheology; 1979; 16(3):179-84. PubMed ID: 508928
    [No Abstract]   [Full Text] [Related]  

  • 15. [Electrophoretic and immunologic studies of joint punctate].
    Scheiffarth F; Götz H; Mohing W; Hecker FH
    Z Rheumaforsch; 1969; 28(3):125-38. PubMed ID: 5819566
    [No Abstract]   [Full Text] [Related]  

  • 16. [Newer aspects of he function of the inner joint parts in arthrosis and chronic polyarthritis].
    Dettmer N; Binzus G
    Dtsch Med J; 1969 May; 20(10):324-31. PubMed ID: 5396907
    [No Abstract]   [Full Text] [Related]  

  • 17. Sialic acid (N-acetylneuraminic acid) in the synovial fluid and serum of patients with inflammatory and non-inflammatory joint disease.
    Omdal R; Aurebekk B
    Scand J Rheumatol; 1985; 14(1):87-9. PubMed ID: 4001883
    [No Abstract]   [Full Text] [Related]  

  • 18. Inactivation of interferon by serum and synovial fluids.
    O'Kelly P; Thomsen L; Tilles JG; Cesario T
    Proc Soc Exp Biol Med; 1985 Mar; 178(3):407-11. PubMed ID: 3919398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytologic, cytochemical and immunocytochemical pattern of synovial fluid in rheumatoid arthritis, in related diseases and in posttraumatic effusions.
    Brühl W; Abgarowicz EM; Chwalińska-Sadowska H; Jakubowski S; Kalczak M; Maldyk H; Wagner T
    Reumatologia; 1970; 8(2):89-93. PubMed ID: 4915236
    [No Abstract]   [Full Text] [Related]  

  • 20. UNUSUAL PROPERTIES OF HYALURONATEPROTEIN ISOLATED FROM PATHOLOGICAL SYNOVIAL FLUIDS.
    HAMERMAN D; SANDSON J
    J Clin Invest; 1963 Dec; 42(12):1882-9. PubMed ID: 14086775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.